Cytomegalovirus Education and Awareness Research Grants
Grants will also improve awareness of the recommended precautions shown to reduce the risk of CMV transmission to pregnant women and will improve the dissemination of this knowledge to the public, to medical practitioners, and to policy makers. (Source: Disabled World)
Source: Disabled World - January 14, 2015 Category: Disability Tags: Awareness Source Type: news
Cytomegalovirus Education and Awareness Research Grants
Stop CMV announces launch of new education and awareness research grants to improve awareness about cytomegalovirus the leading cause of birth defects and developmental disabilities (Source: Disabled World)
Source: Disabled World - January 14, 2015 Category: Disability Tags: Awareness Source Type: news
Valganciclovir May Curb CMV, EBV in Living Kidney DonorsValganciclovir May Curb CMV, EBV in Living Kidney Donors
Antiviral prophylaxis with valganciclovir in living kidney donors may reduce transmission of cytomegalovirus (CMV) and Epstein-Barr virus (EBV), a pilot study suggests. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 5, 2015 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
Pfizer acquires Swiss vaccine developer
As part of an ongoing effort to expand its vaccine business, Pfizer Inc. announced Monday that it has acquired a controlling interest in Redvax GmbH.
Financial terms of the deal were not disclosed.
Redvax was spun out of Redbiotec AG, a privately held Swiss biopharmaceutical company based in Zurich-Schlieren.
The deal gives Pfizer access to Redvax's human cytomegalovirus (CMV) vaccine candidate in preclinical testing, along with the company's intellectual property and a technology platform related… (Source: bizjournals.com Health Care:Hospitals headlines)
Source: bizjournals.com Health Care:Hospitals headlines - January 5, 2015 Category: Hospital Management Authors: John George Source Type: news
Virus Present At Birth Causes More Than 10 Percent of Hearing-Loss Cases in Kids
But most babies don't show symptoms, study says
Source: HealthDay
Related MedlinePlus Pages: Cytomegalovirus Infections, Hearing Problems in Children, Uncommon Infant and Newborn Problems (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - October 27, 2014 Category: Consumer Health News Source Type: news
CMV virus can infect the foetus and cause hearing loss
While Caroline Star, 37, from in Whitechapel, East London, was still expecting, she had caught a little-known but common virus, cytomegalovirus (CMV). (Source: the Mail online | Health)
Source: the Mail online | Health - October 13, 2014 Category: Consumer Health News Source Type: news
Breast Milk a Risk for Spreading Common Virus to Preemies, Study Finds
CMV dangerous for low birth weight infants, but mom can be tested before delivery to see if she carries virus
Source: HealthDay
Related MedlinePlus Pages: Breastfeeding, Cytomegalovirus Infections, Premature Babies (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - September 23, 2014 Category: Consumer Health News Source Type: news
Maternal breast milk is risk factor for cytomegalovirus transmission in premature infants
Premature infants, especially those born with very low-birth-weight, are particularly vulnerable to cytomegalovirus infection because of their immature immune systems. Maternal breast milk is a primary source of postnatal cytomegalovirus in very-low-birth-weight patients, researchers say. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - September 22, 2014 Category: Science Source Type: news
Cytomegalovirus linked to maternal breast milk in very-low-birth-weight infants
(The JAMA Network Journals) The primary source of postnatal infection with cytomagelovirus, a common virus usually without symptoms in very-low-birth-weight infants appeared to be maternal breast milk because no infections were linked to transfusions of cytomagelovirus-seronegative and leukoreduced blood products. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 22, 2014 Category: Infectious Diseases Source Type: news
Maternal breast milk is risk factor for cytomegalovirus transmission in premature infants
(Emory Health Sciences) Premature infants, especially those born with very low-birth-weight, are particularly vulnerable to cytomegalovirus infection because of their immature immune systems. Maternal breast milk is a primary source of postnatal cytomegalovirus in very-low-birth-weight patients. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 22, 2014 Category: Infectious Diseases Source Type: news
What is Gianotti-Crosti Syndrome?
Discussion
Infectious exanthams are usually considered when rashes are bilateral, symmetric and relatively widespread. They usually involve the trunk too and have associated systemic symptoms. Gianotti-Crosti syndrome (GCS) or acropapular dermatitis of childhood is often misdiagnosed because it doesn’t follow these rules. A discussion of common viral exanthams can be reviewed here and a differential diagnosis of rashes by pattern and distributions can be reviewed here.
Dr. Ferdinando Gianotti came from a poor family, underwent several personal tragedies, but entered medicine and created the first department of pedia...
Source: PediatricEducation.org - September 8, 2014 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news
Growth of newborn babies' brains tracked
Conclusion
This study has mapped out the growth rate of the major structures of the brain in 87 apparently healthy neonates from within a week of birth up to 90 days.
A study of this nature can help our understanding of the growth and development of the brain and our ability to monitor brain development over time. The fact the investigation had no apparent side effects is also welcome.
However, as the authors point out, the relatively small size of the study means the results cannot be used as a reference for normal development. Larger and more ethnically diverse studies would be required.
The goal of establishing data ...
Source: NHS News Feed - August 12, 2014 Category: Consumer Health News Tags: Pregnancy/child Source Type: news
July's top stories: Merck CMV Phase III trial, Sanofi vaccine study results
Merck enrolled the first patient in its global Phase III clinical trial of letermovir for the prevention of cytomegalovirus infection in high-risk bone marrow transplant patients, while Sanofi Pasteur reported positive results from its Phase III deng… (Source: Drug Development Technology)
Source: Drug Development Technology - August 4, 2014 Category: Pharmaceuticals Source Type: news
Merck begins Phase III letermovir trial for prevention of CMV infection
US-based pharmaceutical firm Merck has enrolled the first patient in a global Phase III clinical trial of letermovir (MK-8228), an investigational antiviral agent, for prevention of cytomegalovirus (CMV) infection in high-risk bone marrow transplant … (Source: Drug Development Technology)
Source: Drug Development Technology - July 24, 2014 Category: Pharmaceuticals Source Type: news
Merck Initiates Phase 3 Study of Letermovir, an Investigational Antiviral for Prevention of Cytomegalovirus (CMV) Infection in High-Risk Bone Marrow Transplant Patients
Dateline City:
WHITEHOUSE STATION, N.J.
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada,
today announced that the first patient has been enrolled in a global
Phase 3 clinical study of letermovir (MK-8228), an investigational
antiviral agent.
Language:
English
Contact:
MerckMedia:Pam Eisele, 267-305-3558orRobert Consalvo, 908-423-6595orInvestor:J...
Source: Merck.com - Research and Development News - July 24, 2014 Category: Pharmaceuticals Tags: Research and Development News Corporate News Latest News Source Type: news
